Back
Predictive Oncology Quote, Financials, Valuation and Earnings
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
44
POAI
Predictive Oncology
Last Price:
0.75
Seasonality Move:
4.2%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradePredictive Oncology Price Quote
$0.75
-0.06 (-7.41%)
(Updated: November 14, 2024 at 11:35 AM ET)
Predictive Oncology Key Stats
Sell
44
Predictive Oncology (POAI)
is a Sell
Day range:
$0.70 - $0.89
52-week range:
$0.55 - $3.76
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.89
P/B ratio:
1.28%
Volume:
145.1K
Avg. volume:
115.8K
1-year change:
-74.61%
Market cap:
$5.2M
Revenue:
$1.8M
EPS:
$-3.35
How Much Does Predictive Oncology Make?
-
How Much Are Predictive Oncology's Sales Annually?
POAI Revenues are $1.8M -
How Much Profit Does Predictive Oncology's Make A Year?
POAI net income is -$14M
Is Predictive Oncology Growing As A Company?
-
What Is Predictive Oncology's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.43% -
What Is Predictive Oncology's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Predictive Oncology Stock Price Performance
-
Did Predictive Oncology Stock Go Up Last Month?
Predictive Oncology share price went up by 31.86% last month -
Did POAI's Share Price Rise Over The Last Year?
POAI share price fell by -74.61% over the past 1 year
What Is Predictive Oncology 52-Week High & Low?
-
What Is Predictive Oncology’s 52-Week High Share Price?
Predictive Oncology has traded as high as $3.76 over the past 52 weeks -
What Is Predictive Oncology’s 52-Week Low Share Price?
Predictive Oncology has traded as low as $0.55 over the past 52 weeks
Predictive Oncology Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Predictive Oncology?
-
How Much Debt Does Predictive Oncology Have?
Total long term debt quarterly is $276.9K -
How Much Cash Does Predictive Oncology Have?
Cash and short term investments quarterly total is $5.3M -
What Is Predictive Oncology’s Book Value Per Share?
Book value per share is 0.72
Is Predictive Oncology Cash Flow Positive?
-
What Is POAI Cash Flow From Operations?
Cash flow from operations (TTM) is -$12.8M -
What Is Predictive Oncology’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.4M -
What Is Predictive Oncology’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.1K
Predictive Oncology Return On Invested Capital
-
Is Management Doing A Good Job?
POAI return on invested capital is -161.36% -
What Is Predictive Oncology Return On Assets?
ROA measures how assets are converting to revenues and is -93.92% -
What Is POAI Return On Equity?
ROE is a measure of profitability and is -164.1%
Predictive Oncology Earnings Date & Stock Price
-
What Is Predictive Oncology's Stock Price Today?
A single share of POAI can be purchased today for 0.81 -
What Is Predictive Oncology’s Stock Symbol?
Predictive Oncology trades on the nasdaq under the ticker symbol: POAI -
When Is Predictive Oncology’s Next Earnings Date?
The next quarterly earnings date for Predictive Oncology is scheduled on November 14, 2024 -
When Is POAI's next ex-dividend date?
Predictive Oncology's next ex-dividend date is November 14, 2024 -
How To Buy Predictive Oncology Stock?
You can buy Predictive Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Predictive Oncology Competitors
-
Who Are Predictive Oncology's Competitors?
Below is a list of companies who compete with Predictive Oncology or are related in some way:
Predictive Oncology Dividend Yield
-
What Is POAI Dividend Yield?
Predictive Oncology’s dividend yield currently is 0% -
What Is Predictive Oncology’s Payout Ratio?
Predictive Oncology’s payout ratio is 0% -
When Did Predictive Oncology Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Predictive Oncology’s Dividend Per Share?
Predictive Oncology pays a dividend of $0.00 per share
Predictive Oncology Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -43.13% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 3.00 |
| Upside from Last Price: | 270.37% |